23 April 2024 - EMA has published a number of recommendations to address vulnerabilities in the production and delivery of medicines ...
17 April 2024 - International regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
5 April 2024 - The EMA said in a new reflection paper that it will consider granting conditional marketing approval ...
22 March 2024 - Eisai announced today that the oral explanation scheduled for 19 March at the CHMP for lecanemab, ...
28 February 2024 - Added benefit was evaluated using ratings published by seven organisations: health technology assessment agencies from the US, ...
15 February 2024 - The EMA and the Heads of Medicines Agencies have launched two public electronic catalogues: one for ...
25 January 2024 - PTC Therapeutics announced today that the CHMP of the EMA issued a negative opinion following the re-examination ...
16 January 2024 - In 2023, EMA recommended 77 medicines for marketing authorisation. ...
19 December 2023 - Biogen today announced that the European Commission has revoked the centralised marketing authorizations for generic versions ...
18 December 2023 - The EMA and the Heads of Medicines Agencies have published an artificial intelligence workplan to 2028, ...
14 December 2023 - Apellis Pharmaceuticals announced today an update on the on-going review of its marketing authorisation application for ...
12 December 2023 - The European Commission, the Heads of Medicines Agencies and EMA have published the first version of the ...
5 December 2023 - EMA has relaunched its website: www.ema.europa.eu. ...
1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...
9 November 2023 - The EMA is relaunching its corporate website on 5 December 2023. ...